Participatory Healthcare public [search 0]
×
Join millions of Player FM users today to get news and insights whenever you like, even when you're offline. Podcast smarter with the free podcast app that refuses to compromise. Let's play!
Join the world's best podcast app to manage your favorite shows online and play them offline on our Android and iOS apps. It's free and easy!
More
show episodes
 
Shirley shines a light on current change and innovations in our society. There is currently a primary focus on the social business environment, healthcare leaders and healthcare consumers. Join her for Social Media Pearls.
 
DIA is a global, multidisciplinary, membership association of healthcare professionals that works towards the advancement of lifesaving medicines, therapies, and technologies around the world.
 
Mad*Pow is a design agency that improves the experiences people have with technology, organizations, and each other. Listen in on interviews with our thought leaders on topics like Behavior Change Design, Organizational Design, Usability Tests, Development, Improving Healthcare Experiences, Empathy, User Experience, Experience Strategy and Service Design, and much, much more!
 
Loading …
show series
 
“Though there's different perspectives, and different reasons why we're all in healthcare, it is all about the patient; and so, getting patient access to important therapeutics that change their lives is why we're all here,” suggests Sandra Milligan, Senior Vice President, Head of Global Regulatory Affairs and Clinical Safety, Merck. “It's amaz ...…
 
Japan’s Clinical Research Act, which came into force in April 2018, codified the term “clinical research” for the first time in the nation’s history. “‘AI’ has become a big buzzword and it is making a huge impact on the way we conduct clinical trials, as well as on various areas of R&D activities,” explains Dr. Takashi Sato, Manager for Kyowa K ...…
 
Through FDA’s Patient Focused Drug Development and similar initiatives, the value of the patient voice in drug development is clear. “It’s not just a question of science but also one of social justice,” suggests independent filmmaker Jennifer Brea, Director for Shella Films and founder of the rare disease community MEAction. “When no one’s payi ...…
 
“Patient engagement is a subset of participatory medicine. Participatory medicine is about partnership between the patient and the clinical or scientific expert,” explains “ePatient Dave” deBronkart. “The whole purpose, the context, for this entire initiative is not to have physicians feel threatened, but to help healthcare achieve its potentia ...…
 
In March 2019, the Health Ministry of India released new guidelines for clinical research. What is the state of pre-market and post-market safety for patients and drugs in India, six months after these new guidelines were announced? Dr. Srikanth Krishnamurthy, a consulting pulmonologist at Sri Bala Medical Centre and Hospital, discusses the pre ...…
 
Where is real world data providing evidence that impacts therapeutic product development? “We're learning that, right now, the near-term uses are probably around label expansion and around providing information on new populations that's valuable but wasn't captured in randomized clinical trials or could not be captured in those trials,” explain ...…
 
“We understand we need to educate people wherever they are about the power of personalized medicine,” says Edward Abrahams, President of the Personalized Medicine Coalition, which promotes the understanding and adoption of personalized medicine concepts. “We look forward to the day when patients ask, ‘Is this going to work for me?’ And we look ...…
 
FDA released its long-anticipated Communications with Payer Guidance in late 2018. “With rising healthcare costs, it's ever more important for payers to make the right informed decisions about access. From an industry perspective, we have to help them think about the value of the products,” suggests Sissi Pham, Founder and CEO of AESARA, Inc. a ...…
 
Cell and gene therapy are raising new ethical questions in clinical research and practice. “It will probably be the case that breast cancer, which now affects both wealthy people and poor people, will increasingly be a disease of poor people because wealthy people were able to get rid of the mutation from their families,” suggests Robert Klitzm ...…
 
“Peoples’ data is valuable. We know that researchers want it. And people should be rewarded for sharing it,” suggests Dawn Barry, President and Co-founder of the public benefit corporation LunaPBC. In 2018, LunaPBC launched LunaDNA, a genomic medical research database owned by its community: LunaDNA members share in the platform’s value through ...…
 
As Johnson & Johnson Chief Medical Officer, DIA 2019 Co-Chair Dr. Joanne Waldstreicher is responsible for the company’s collaborations in ethical science, technology, and R&D policies, including those related to clinical trial transparency and compassionate access. “When you ask people why they’re participating in a clinical trial, a big part o ...…
 
The emerging digital healthcare landscape is already becoming quite visible around the world, especially in Japan. But what is the true impact of digital technology on clinical research, drug development, and healthcare? “Imaging data plus AI is one of the best combinations,” explains Dr. Kazuhiro Kanmuri, Founder and Chief Executive Officer of ...…
 
Conversations about disparate healthcare access often address therapies approved for market, but how can we ensure equity in the clinical R&D processes that generate these therapies? “There’s not a ‘one size fits all’ approach to overcoming all the barriers to recruiting diverse participants in clinical trials, and there may be specific conside ...…
 
“Digitization is something that is happening to everything that we do. It’s being called the fourth industrial revolution,” explains Dr. Robert Califf, former FDA Commissioner and Vice Chancellor for Health Data Science at Duke Health. “And if we do it right, it will actually free up clinicians to spend more time directly with people and, when ...…
 
Do changes in clinical research, driven by emerging technology, change what we mean by “evidence”? “It’s not necessarily ‘trials versus real world evidence’–that is not particularly helpful because either type of evidence, either type of data, has its place and is complementary,” explains Mr. Michael Seewald, WorldWide Head of the Center of Exc ...…
 
“One critical area when you look at healthcare systems is the issue of optimizing clinical and operational effectiveness,” suggests Professor John Lim, founding Executive Director of the Duke-National University of Singapore Centre of Regulatory Excellence (CoRE). “This is an area where research in AI is developing to really inform and aid deci ...…
 
“China joining ICH is a magnificent milestone for the pharmaceutical industry in China,” explains Dr. Jingsong Wang, Chairman and Chief Executive Officer of Harbour Biomed. “We can see clearly more and more local pharmaceutical companies adopting the international standards to have a more innovative portfolio to face the competition from their ...…
 
Should prescription drug or device advertisements include their price? “I don’t know how patients will perceive that because they won’t really know the difference between what they may or may not end up paying,” suggests Micheline Awad, Director, Regulatory Affairs, Advertising & Promotion, Neurocrine Biosciences, Inc. “We really haven’t studie ...…
 
Dr. Yoshiaki Uyama, Director of the Office of Medical Informatics & Epidemiology for the Pharmaceuticals and Medical Devices Agency (PMDA), Japan, and DIA Global Forum Regulatory Science co-editor, shares his vision for utilizing real world evidence in regulatory science. “The challenge is, we still don’t understand completely the characteristi ...…
 
In 2018, the US FDA approved a record high number–59–of new, novel drugs. “We are at a point now where there is so much innovation in this space and the regulatory aspects are catching up, so we now have three approved gene therapy products in the US and over seven to eight hundred INDs for cell and gene therapy filed with FDA,” explains Dr. Ad ...…
 
Listen in to Mad*Pow's podcast with Jen Briselli Managing Director of Experience Deign at Mad*Pow to learn what value participatory design can bring to your process and how to use it in your organization, including hands-on opportunities to try out fundamental tools, exercises and so forth. That and much more!…
 
Mad*Pow's James Christie and Jen Briselli founded and hosted the Sustainable UX conference that was held in February. Hear the podcast on the idea behind it and what's in store, next!
 
Mad*Pow's podcast series hosts Managing Director of Experience Strategy & Design, Jen Briselli, who discusses education and design's role in new educational platforms. How far education has come, what's new in the space, and what's left to be done.
 
If your personal or professional mission includes transforming the healthcare system through improved engagement, empowerment, empathy and efficiency, listen here to an interview with with Amy Cueva, Founder, Chief Experience Officer of Mad*Pow and Kelly Connors blogger of "Real Women on Health!"
 
Mad*Pow's Chris Hass interview's Mad*Pow's Ciara Taylor and Samantha Dempsey, the curators behind the Mad*Pow project, Designer's Oath. Read more about the Designer's Oath at www.designersoath.com.
 
Adam Connor, designer at MadPow and author of "Discussing Design" with Aaron Irizarry — Connor also will be speaking at O’Reilly’s inaugural Design Conference, talks about company culture and organizational design, the design of codes of conduct, and advice on running productive design critiques.
 
Listen in to Mad*Pow's podcast series with Mad*Pow's host, Chris Hass as he interviews Adam Connor, head of Mad*Pow's organizational design and training team on his book, "Discussing Design". In this podcast, you'll hear about what you and your team can do you maximize the benefits of critique, strengthen collaboration, and hear the good the ba ...…
 
Check out this episode of Digital PM Radio where Carl Smith talks to Digital PM Summit 2015 speakers and authors of Discussing Design Adam Connor and Aaron Irizarry about how they partnered up to help people give better design critiques, the Digital PM Summit, and how their topic is a great one for any digital PM.…
 
In this episode of Give Startups A Chance, I am thrilled to interview Nicole Judge and Thomas Wilson as they share their startup journey in rural Canada while introducing Canada to an age-old delight of Cider. Dr. Nicole Judge is a veterinarian and her husband, Thomas Wilson, a fifth generation farmer, is also the past president of the Peel Soi ...…
 
I am thrilled to interview Marie Ennis-O'Connor in this show. Marie is a breast cancer survivor. Marie shares her journey and what survivorship means to her. She shares her learnings and decisions she made as a cancer patient and young women. She highlights the impact of those decisions as part of managing her survivorship. So do join me for th ...…
 
It is my total pleasure to interview Gavin McGarry, Founder of JUMPWIRE MEDIA. Gavin is a wonderful example of the passion you need to be a serial entrepreneur. Join me for this interview as Gavin shares his journey and story as a serial entrepreneur and establishing JUMPWIRE MEDIA. Fast Company has listed JUMPWIRE MEDIA in the top10 most innov ...…
 
I am thrilled to have as my Guest Drew Green! Founder of SHOP.CA In this interview, Drew shares his journey from concept to market in his launch of SHOP.CA and the kind of talent and culture that he has nutured to succeed. Join us to learn about his amazing road to startup success. Guest Bio Drew is founder, CEO and chairman of SHOP.CA Having s ...…
 
I a thrilled to have Andrew D'Souza as my guest. Andrew is no stranger to startups and has worked both side of borders in the US and Canada. I found his recent post on Venture Capital in Canada so insightful, I had to invite him to my show. In this episode, Andres shares his perspective on Attitudes, Talent and Investment in StartUps. Guest Bio ...…
 
Listen in to Mad*Pow's podcast series with Mad*Pow's host, Chris Hass as he interviews Adam Connor, head of Mad*Pow's organizational design and training team on his book, "Discussing Design". In this podcast, you'll hear about what you and your team can do you maximize the benefits of critique, strengthen collaboration, and hear the good the ba ...…
 
Google login Twitter login Classic login